COVID-19

A disease caused by infection with severe acute respiratory syndrome coronavirus 2.

Aliases

2019 novel coronavirus
2019 novel coronavirus infection
2019-nCoV
2019-nCoV infection
beta-CoV
beta-CoVs
betacoronavirus
coronavirus disease 2019
SARS-coronavirus 2
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
severe acute respiratory syndrome coronavirus 2 infectious disease
β-coronavirus
β-CoV
β-CoVs

Studies related to COVID-19 Advanced search

Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection

Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis

Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19

Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza

Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients

Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients

The active lung microbiota landscape of COVID-19 patients through the metatranscriptome data analysis

The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort

Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai

Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients

SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition

Six-month follow-up of gut microbiota richness in patients with COVID-19

Alterations in the human oral and gut microbiomes and lipidomics in COVID-19

Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19

Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?

Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases

Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults

Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery

Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19

Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19

Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing

Integrated gut virome and bacteriome dynamics in COVID-19 patients

Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients

Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization

Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19

Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever

Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19

Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study

16S rRNA gene sequencing of rectal swab in patients affected by COVID-19

Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18

SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome

The lower respiratory tract microbiome of critically ill patients with COVID-19

Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization

Acute SARS-CoV-2 infection is associated with an expansion of bacteria pathogens in the nose including Pseudomonas Aeruginosa

Nasopharyngeal Microbiome Community Composition and Structure Is Associated with Severity of COVID-19 Disease and Breathing Treatment

Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types

Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge

Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients

Altered infective competence of the human gut microbiome in COVID-19

Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection

Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 +

Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort

Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients

Characterization of oral bacterial and fungal microbiome in recovered COVID-19 patients